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Murine embryo fibroblasts (MEF) transcribe tumor necrosis factor (TNF) mRNA and secrete soluble TNF in response to infection by
West Nile virus (WNV) and TNF was demonstrated to be protective against WNV infection in vitro. TNF is not required for the WNV-
induced upregulation of MHC-I expression on MEF, as TNF deficiency did not affect the upregulation of major histocompatibility complex
class I (MHC-I) by WNV. Furthermore, NF-nB was activated by WNV in TNF-deficient MEF, demonstrating that WNV induces NF-nB
activation in a TNF-independent manner. The subunits of NF-nB activated by TNF and WNV differed, WNV-activated a p65/p50 NF-nB
complex while TNF-activated NF-nB was composed of p65, p50, and c-Rel. Furthermore, TNF-induced activation of NF-nB occurred earlier
than WNV-induced NF-nB activation. The data demonstrate that WNV infection of MEF is associated with TNF production, but the WNV-
induced activation of NF-nB and subsequent upregulation of MHC-I by WNV is TNF-independent.
D 2004 Elsevier Inc. All rights reserved.
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Members of the genus, Flavivirus, cause a range of
serious diseases, including yellow fever, dengue and various
encephalitides, with significant morbidity and mortality
throughout the world (Burke and Monath, 2001). Flavivi-
ruses have recently risen to public health prominence with
the spread of West Nile virus throughout most of North
America, starting with an outbreak of encephalitis in New
York in August 1999, in which there was approximately
10% mortality (Nash et al., 2001).
There is increasing evidence that a significant aspect of
disease caused by these viruses is associated with pathology0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: alisonk2@chw.edu.au (A.M. Kesson).induced by a dysregulated immune response. Possible
causes of this include direct or indirect effects of various
cytokines, including for example, tumor necrosis factor
(TNF), as well as flavivirus-specific induction of increased
immune recognition molecule expression, notably major
histocompatibility complex class I (MHC-I) (Andrews et al.,
1999; King and Kesson, 1988, 2003).
In vivo, increased levels of TNF have been detected in
the serum of patients infected with dengue virus (Hober et
al., 1996, 1998) and TNF induction has been shown in
dendritic cells (Ho et al., 2001) and human peripheral blood
leukocytes infected by dengue virus in vitro (Chaturvedi et
al., 1999; Mori et al., 1997). TNF can co-regulate immune
recognition molecules induced by West Nile virus (WNV)
(Shen et al., 1997). Thus, flaviviruses influence the
regulation of TNF and its downstream effects.
Tumor necrosis factor (TNF) is produced by macro-
phages and T cells in response to stimuli, but also by a
variety of other cells, including fibroblasts (Kock et al.,04) 361–370
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produce TNF in response to stimulation by bacteria (Havell
and Sehgal, 1991) and bacterial components, such as
endotoxin (Havell and Rogerson, 1993).
Its normal effects, among others, are directed towards the
immune response against invading organisms. Antiviral
activity, one of the principal functions of TNF, is induced
during infection with both RNA and DNA viruses. TNF
enhances or inhibits viral replication depending on the virus
involved and cell type infected, since the binding of TNF to
the TNF receptor can activate, differentiate, or kill infected
target cells. TNF also blocks viral replication by interfering
with the virus life cycle, especially viral entry. TNF is
involved in inducing networks of cytokines and chemokines
that draw immune cells into infectious foci and synergisti-
cally enhance the antiviral activity of interferons. On the
other hand, viruses have co-evolved with their hosts to
evade TNF responses and thus enable viral spread. In the
complicated balance between the control of viral replication
and the necessary regulation of antiviral responses by the
host, the TNF/TNF-receptor pathway is a key component
that influences the pathogenesis of many viral infections
(Herbein and O’Brien, 2000).
Synthesis of TNF is regulated at both transcriptional and
translational levels. The elements which regulate TNF
promoter activity by binding to transcription factors, are
located within 100 bp of the mRNA start site. Nuclear
factor-kappa B (NF-nB) plays a major role in transcriptional
regulation of TNF mRNA with the TNF gene promoter
containing at least two binding sites for NF-nB (Jongeneel,
1992; Willeaume et al., 1995).
TNF itself induces MHC-I expression through NF-nB
activation, as well as enhancing the upregulation of MHC-I
by interferons (IFNs) mainly via a cooperative action of Rel/
NF-nB and interferon response factor-1 transcription fac-
tors, respectively (Drew et al., 1995; Johnson and Pober,
1994). We have previously shown WNV-induced upregula-
tion of MHC-I is associated with significant activation of
NF-nB. We therefore investigated whether TNF was
involved in WNV-induced NF-nB activation and subsequent
MHC-I upregulation. We show here, for the first time, that
while TNF can activate NF-nB and upregulate MHC-I on
cell surface in its own right, the effects mediated by WNV
are WNV-specific and independent of the actions of
endogenously secreted TNF.Fig. 1. (A) Transcription of TNF mRNA by WNV in WT MEF. Panel a,
detection of TNF mRNA and panel b, detection of h-actin mRNA by
reverse transcription, polymerase chain reaction and gel electrophoresis.
Lane 1, mock-infected; lanes 2 and 4, infected with WNV at 100 pfu per
cell; lanes 3 and 5, infected with WNVat 5 pfu per cell; lane 6, treated with
LPS (50 ng per ml) for 4 h; lanes 2 and 3, 24 h infection; lanes 4 and 5, 8 h
infection; lane 7, negative control. (B) Production of soluble TNF protein
by MEF in response to WNV infection. MEF were infected with WNV at
2.5, 5, or 10 pfu per cell or left uninfected and incubated for 48 h. The
supernatants from both infected and uninfected cultures were collected and
the amount of secreted soluble TNF in supernatant was detected by ELISA.
The results show mean of duplicate samples + standard deviation.Results
Transcription of TNF mRNA and production of soluble TNF
in WNV-infected MEF
Since TNF production is a prominent part of dengue
virus infection, we wished to determine if TNF mRNA
expression was specifically induced in response to WNV
infection.Mouse embryo fibroblasts (MEF) were infected with
WNV at 100 pfu per cell and 5 pfu per cell for 8 h, 24 h or
mock-infected. Four-hour, LPS-treated (50 ng per ml) MEF
were used as a positive control. Total RNA was extracted
from the MEF and reverse transcribed as described in
Materials and Methods. An equal amount of cDNA from
each sample was subjected to PCR with specific primers for
the mouse TNF gene or primers for the house-keeping gene,
murine h-actin. A negative control with distilled water was
included in all PCR assays to detect contamination. The
PCR products were separated on a 2% agarose gel and the
product size calibrated against a DNA ladder. Transcription
of TNF mRNA was detected in MEF infected with a high
multiplicity of infection (moi) (100 pfu per cell) but not with
low moi (5 pfu per cell) at 8 h infection, while TNF mRNA
was clearly induced by 24 h infection at both 100 and 5 pfu
per cell (Fig. 1A).
To determine whether transcribed mRNA resulted in
increased soluble TNF production, the supernatants from
WT MEF, infected with WNV at 2.5, 5, and 10 pfu per cell
or mock-infected, were collected at 48 h after infection and
soluble TNF determined by ELISA. A statistically signifi-
cant increase in production of soluble TNF was detected in
the supernatant of MEF infected with WNVat 2.5, 5, and 10
pfu per cell (P b 0.001) (Fig. 1B). This demonstrates that
soluble TNF is produced, and secreted by WNV-infected
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TNF in MEF at 24 h after WNV infection.
Effect of TNF on WNV infection
As TNF has variable effects on virus-infected cells
(Herbein and O’Brien, 2000), we determined the effects of
TNF on MEF during WNV infection. MEF derived from
TNF/ and WT mice were seeded into 24-well plates on
glass coverslips and infected with WNV at 10, 5, 2.5, 1.25,
and 0.625 pfu per cell for 24 h. The percentage of WNV-
infected cells at each dilution of WNV was then determined
by antibody labeling and fluorescence microscopy. The
percentage of WNV-infected cells in TNF/ MEF was
statistically significantly higher than that in WT MEF (P b
0.001) at each dilution (Table 1), that is, TNF/MEF were
more susceptible to WNV infection than WT MEF. This
demonstrates that TNF plays an important role in the
defence mechanism of MEF against WNV infection.
Since interferon-a/h (IFN-a/h) plays a key role in the
cellular anti-viral defence mechanisms, the possible con-
tribution of endogenously produced IFN-a/h in WNV
infection in both TNF/ MEF and WT MEF was removed
with neutralizing antibodies to IFN-a/h. Both TNF/MEF
and WT MEF were infected with WNVor mock-infected for
1 h, then incubated under SCC with 200 units per ml of anti-
IFN-a/h antibody (previously titrated to determine maximal
neutralizing effect, data not shown) or mock-treated for 24
h. The MEF were then fixed and labeled with anti-WNV
antibodies and the percentage of WNV infected cells
determined by fluorescence microscopy. As previously
shown, neutralization of IFN-a/h increased the suscepti-
bility of WT MEF to WNV infection (Douglas et al., 1994).
Treatment with anti-IFN-a/h also caused a statistically
significant increase in the susceptibility to WNV infection of
the TNF/ MEF at the two highest doses of WNV used
(Table 1). Thus, TNF/MEF remained more susceptible to
WNV infection than the WT MEF in the presence of
neutralizing anti-IFN-a/h antibodies. This suggests thatTable 1




WT MEF Nil 10 F 2 4
TNF/ MEF 30 F 10 1
P value* b0.001 b
WT MEF anti-IFNa/h nd 1
TNF/ MEF (200 U/ml) nd 2
P value** 0
TNF/ MEF and WT MEF were grown on coverslips and infected with serial-di
24 h. The results are expressed as the mean percentage of 6 fields of view on ea
performed three times and a representative experiment is shown. The Percentage
anti-IFN-a/h. P values b 0.05 were considered significant. nd = not done.
* P value compares percentage infection of TNF/ MEF with WT MEF.
** P value compares percentage of infection of TNF/ MEF with and withoutTNF has a separate antiviral activity which is independent
of the action of endogenous secretion of type 1 IFN.
The antiviral effect of TNF was further confirmed by
addition of recombinant TNF to WNV-infected WT, TNF/
and IFNAR/MEF. After infecting theMEFwith 20 pfu per
cell WNV for 1 h, 200 units per ml recombinant TNF was
added to cultures or the cultures were left untreated. The
percentage of infected cells was lower in the presence of TNF
in each individual type of MEF, but a statistically significant
decrease in infection was found in both the TNF-treated
IFNAR/ and TNF/ MEF, compared with the untreated
matched controls (Table 2). This further demonstrates that
TNF has an antiviral effect, which is independent of the
endogenous production of IFN-a/h in WNV-infected MEF.
However, these experiments also show that addition of TNF
in vitro does not fully reconstitute the antiviral state exhibited
by the WT MEF.
The role of TNF in WNV-induced MHC-I upregulation
We wished to determine whether endogenously secreted
TNF contributed to MHC-I upregulation in WNV-infected
MEF. Although flavivirus-induced MHC-I upregulation is
partially independent of endogenous IFN-a/h production
(King and Kesson, 1988; King et al., 1989) TNF can
enhance IFN-h synthesis which could further contribute to
the MHC-I upregulation in WNV-infected cells (Herbein and
O’Brien, 2000). Furthermore, TNF can upregulate MHC-I in
its own right (David-Watine et al., 1990; Todd, 1995) and
IFN-a/h and TNF have a synergistic effect on MHC-I
upregulation (Johnson and Pober, 1994). Finally, TNF can
co-modulate WNV-induced upregulation of various immune
recognition molecules on endothelium (Shen et al., 1997).
TNF/ and WT MEF were infected with WNV or
treated with IFN-h or mock-infected for 24 h. The cells
were then labeled with anti-MHC-I and SAM-FITC for
detection of cell surface MHC-I expression by flow
cytometry. Fig. 2 shows that TNF deficiency did not affect
the upregulation of MHC-I by WNV or IFN-h. Not anti-IFN-a/h
2.5 1.25 0.625
F 1 3 F 1 2 F 1 1 F 1
8 F 5 12 F 2 9 F 2 4 F 1
0.001 b0.001 b0.001 b0.001
2 F 2 6 F 2 4 F 2 nd
8 F 6 20 F 3 13 F 5 nd
.011 0.003 0.089
lutions of WNV either with anti-IFN-a/h (200u per ml) or left untreated for
ch sample of infected cells F the standard deviation. This experiment was
of cells infected by WNV in TNF/ MEF and WT MEF with presence of
anti-IFN-a/h.
Table 2







% Infection WNV 28.8 F 4.8* 74 F 7.5 64 F 6.3
n = 7 n = 6 n = 7
WNV + TNF
(200 U/ml)
24.6 F 6.6 62 F 9.1 56 F 7.8




WT, IFNAR/ and TNF/ MEF were grown on coverslips and infected
with WNV (20 pfu per cell) for 1 h and incubated with or without TNF
(200u per ml) for 24 h. The results are expressed as the mean percentage of
infected cells F the standard deviation. This experiment was performed
three times and a representative experiment is shown. The P value
compares the WNV-infected with the WNV-infected and TNF-treated MEF.
P b 0.05 were considered significant.
n = number of fields of view.
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between WT and TNF/ MEF either infected with WNV
(Figs. 2a and 2c) or treated with IFN-h (Figs. 2b and 2d).
These data indicate that TNF is not required to upregulate
MHC-I on WNV-infected TNF/ MEF and imply that
TNF is not essential in MHC-I upregulation by WNV in
WT MEF.
To determine whether TNF contributes to the MHC-I
upregulation mediated by WNV-induced IFN-h, we
infected or mock-infected WT and IFNAR/ MEF with
WNV, with and without added TNF, treating both cell types
with TNF alone, as a control. Fig. 3 shows that baseline
MHC-I expression on mock-infected WT and IFNAR/
MEF was similar, with MHC-I being approximately 5-fold
the level of detectable isotype control antibody fluorescenceFig. 2. Upregulation of MHC-I by WNVor IFN-h on TNF/ and WT MEF. Indu
and TNF/MEF (panels c and d). The MEF were infected with WNV (5 pfu per c
The bold line indicates WNV-infected or IFN-h-treated, the plain line indicates untr
the FACS analysis show fluorescence intensity divided into channels expressed ain both cell types. MHC-I was upregulated on both WT and
IFNAR/ MEF infected with WNV, although, as
expected, in the absence of the type 1 IFN receptor,
MHC-I induction was significantly lower than in the WT
MEF (Figs. 3a, b). Treatment of both cell types with TNF
only produced equivalent small increases in MHC-I
expression (Figs. 3c, d). Thus, type 1 IFN is not required
for TNF-mediated upregulation of MHC-I. The combina-
tion of WNV infection and TNF treatment of WT and
IFNAR/ MEF also resulted in MHC-I increases in both
cell types (Figs. 3e, f), which occurred in a very similar
pattern to that seen with WNV infection alone (Figs. 3a, b).
Thus, induction of increased MHC-I expression by WNV is
greatest in the presence of induced functional endogenous
type 1 IFN and addition of TNF does not further increase
the level of MHC-I expression. These data also support our
previous observation that, other than IFN, no other cytokine
contributes significantly to upregulation of MHC-I in
WNV-infected MEF (Cheng et al., 2004).
The role of TNF in WNV-induced NF-jB activation
TNF is a potent activator of NF-nB in many types of
cells (Baldwin, 1996) and WNV-induced MHC-I upregula-
tion is associated with significant NF-nB activation (Kesson
and King, 2001). We therefore wished to determine whether
TNF production was involved in WNV-induced NF-nB
activation. TNF/ and WT MEF were infected with WNV
or mock-infected or treated with TNF and total cell protein
was extracted after 24 h of culture. Equal amounts of protein
were analyzed in an EMSA using 32P-labeled oligonucleo-
tide with a high affinity binding site for NF-nB.ction of increased expression of H-2b (KbDb) on WT MEF (panels a and b)
ell) (panels a and c) or treated with IFN-h (200 units per ml) (panels b and d).
eated and the broken line indicates isotype control antibody. The results from
s arbitrary units (abscissa) against cell number in each channel (ordinate).
Fig. 3. The effect of TNF on WNV-induced MHC-I upregulation on WT and IFNAR/ MEF. Induction of increased expression of H-2b (KbDb) on WT MEF
(panels a, c and e) and IFNAR/ MEF (panels b, d, and f). The MEF were infected with WNV (5 pfu per cell) (panels a and b), treated with TNF (200 units
per ml) (panels c and d) or both infected with WNV (5 pfu per cell) and treated with TNF (200 units per ml) (panels e and f). The plain line indicates treated
MEF, the dotted line indicates untreated MEF and the vertical broken line indicates mean peak fluorescence of the isotype control antibody. The results from
the FACS analysis show fluorescence intensity divided into channels expressed as arbitrary units (abscissa) against cell number in each channel (ordinate).
Fig. 4. (A) Activation of NF-nB in WNV-infected or TNF-treated WT or
TNF/ MEF. Lanes 1 to 3 WT MEF, lanes 4 to 6 TNF/ MEF. Lanes 1
and 4, mock infected; lanes 2 and 5, infected with 5 pfu per cell WNV for
24 h; lanes 3 and 6 treated with 500 units per ml TNF for 24 h. The NF-nB
band is indicated by the arrow. (B) Effect of anti-TNF antibody on WNV-
induced activation of NF-nB in WT MEF. Lane 1 and 2, control IgG; lanes
3 and 4, 500 units per ml anti-TNF; lanes 1 and 3, mock infected; lanes 2
and 4 infected with 5 pfu per cell WNV for 24 h. The NF-nB band is
indicated by the arrow.
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treated TNF/ MEF at levels similar to that in WT MEF
(Fig. 4A). This indicates that WNVactivates NF-nB in MEF
in a TNF-independent manner.
To further confirm that WNV-induced NF-nB activation
occurred independently of TNF production, we infected or
mock-infected WT MEF with WNV and treated them with
neutralizing anti-TNF antibody or an isotype control IgG.
WNV-induced NF-nB activation, both in WT MEF treated
with anti-TNF or treated with isotype control antibody
(Fig. 4B). Taken together, this shows that WNV-induced
NF-nB activation can occur independently of the action of
endogenously secreted TNF.
The components of NF-jB activated by TNF are different
from those activated by WNV infection
NF-nB plays a central role in the regulation of the
expression of a large number of genes involved in
inflammatory responses (Lenardo and Baltimore, 1989).
The specificity of regulation of particular genes by NF-nB
may be achieved by permutations of the activated NF-nB
Fig. 6. Differing kinetics of NF-nB activation by WNVand TNF. Lanes 1 to
3, 8 h treated MEF, lanes 4 to 6 are 24 h treated MEF. Lanes 1 and 4, mock-
treated; lanes 2 and 5, infected with 5 pfu per cell WNV infected, lanes 3
and 6, treated with 500 units per ml TNF.
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Verma, 1995; Siebenlist et al., 1994). We have determined
the subunit composition of WNV-activated NK-nB in WT
MEF (Kesson and King, 2001). However, the possible
contribution by endogenously produced TNF was not
excluded in this work. Therefore, using a supershift assay,
we identified the WNV-induced components of activated
NF-nB in TNF/ MEF, where the action of endogenously
produced TNF is absolutely excluded. We also identified
the components of NF-nB activated by TNF in TNF/
MEF as a control. Total cell protein extracts from 24-h,
WNV-infected or TNF-treated TNF/ MEF were used in
an EMSA in which antibodies to the NF-nB proteins, p65,
p50, and c-Rel, were added to the binding reactions. The
WNV-induced complex binding to the probe is shown in
Fig. 5A. Lane 1 shows the WNV-induced NF-nB binding
complex. Both anti-p65 and anti-p50 antibodies reacted
individually with the binding complex and slowed migra-
tion, shifting the NF-nB binding complex (lanes 2 and 3,
respectively). Anti-c-Rel had no effect (lane 4). The
combinations of anti-p65 and anti-p50, anti-p50 and anti-
c-Rel, anti-p65 and anti-c-Rel and anti-p65 anti-p50 and
anti-c-Rel all shifted the binding complex (lanes 5, 6, 7, and
8, respectively). The shifted bands in lanes 5 to 8 did not
enter the gel due to their high molecular weight and are not
visible. Goat serum was added as a control and did not alter
the mobility of the complex (lane 9). These data identify the
WNV-induced complex which binds NF-nB as being
composed of p65 and p50 but not c-Rel, as previously
described for WT MEF (Kesson and King, 2001).
The TNF-induced complex binding to the probe is shown
in Fig. 5B. Lane 1 shows the TNF-induced binding
complex. Anti-p65, anti-p50, and anti-c-Rel antibodies
individually reacted with the binding complex and slowed
migration shifting the NF-nB binding complex (lanes 2, 3,
and 4, respectively). The combinations of anti-p65 and anti-
p50, anti-p50 and anti-c-Rel, anti-p65 and anti-c-Rel, and
anti-p65, anti-p50 and anti-c-Rel (lanes 5, 6, 7, and 8,
respectively) all shifted the binding complex. The shiftedFig. 5. Supershift of total cell extracts from WNV-infected TNF/ MEF
(panel A) and TNF-treated TNF/ MEF (panel B). Lane 1 WNV-infected
control, lane 2 incubated with anti-p65, lane 3 incubated with anti-p50,
lanes 4 incubated with anti-c-rel, lane 5 incubated with anti-p65 and anti-
p50, lane 6 incubated with anti-p65 and anti-c-rel, lane 7 incubated with
anti-p50 and anti-c-rel, lane 8 incubated with anti-p65, anti-p50 and anti-c-
rel, lane 9 incubated with control goat serum. The NF-nB band is indicated
by the arrow.bands in lanes 5 to 8 again did not enter the gel due to their
high molecular weight and are not visible. Goat serum was
added as a control and did not alter the mobility of the
complex (lane 9). These data indicate that the TNF-induced
complex is composed of p65, p50, and also c-Rel, in
contrast to the WNV-induced complex composed of p65 and
p50 alone. This demonstrates that WNV activates different
heterodimers of NF-nB, compared with TNF and that
activation of NF-nB by WNV is by a TNF-independent
mechanism.
Kinetics of NF-jB activation by WNV and TNF
As both TNF and WNV activate different components of
NF-nB, we wished to determine if there was any difference
in the kinetics of activation of NF-nB by TNF, compared
with WNV. Total cellular proteins from WT MEF treated
with TNF or infected with WNV at an moi of 5 for 8 h and
24 h were collected, and active NF-nB was detected by
EMSA with 32P-labeled NF-nB consensus double-stranded
DNA oligonucleotide. The results shown in Fig. 6
demonstrate that the activation of NF-nB by TNF was
greater at 8 h (lane 3) than at 24 h (lane 6), while WNV-
activated NF-nB was greater at 24 h (lane 5) than that at 8 h
(lane 2). Thus at this moi, the kinetics of NF-nB activation
by WNV differs from activation by TNF, with TNF-
induced NF-nB activation occurring earlier.Discussion
Infection of MEF with the flavivirus, West Nile, is
associated with upregulation of cell surface MHC-I expres-
sion. Class I-restricted antigen presentation plays a crucial
role in anti-viral defences and is critical in the cytotoxic T
cell responses to WNV (Kesson et al., 1987, 1988); the level
of cell surface expression of MHC-I is quantitatively related
to the efficiency of the class-I restricted cytotoxic T cell
response to WNV (Kesson and King, 2001). Cell surface
MHC-I expression can be upregulated by type 1 IFNs and
TNF, both of which are endogenously produced by cells in
response to infection (David-Watine et al., 1990; Todd,
1995).
We have previously shown that the upregulation of
MHC-I by WNV occurs independently of the actions of
endogenously secreted type 1 IFNs (King and Kesson,
1988; King et al., 1989).
In the studies presented here, we have shown that WNV
infection of MEF was associated with transcription of the
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However, detection of TNF gene transcription by WNV was
later than that detected by LPS stimulation and the
production of soluble TNF was undetectable until more
than 24 h after infection.
Investigation of the role of TNF in WNV infection
demonstrated that TNF was associated with protection
against WNV infection. Using TNF/ MEF, which do
not secrete TNF but can respond to the effects of TNF, we
clearly demonstrated a statistically significant increase in the
percentage of WNV-infected cells in the TNF/ MEF,
compared with the WT MEF. As we wished to exclude any
possibility that TNF was protecting against WNV infection
by inducing endogenous IFN production, we measured the
percentage of infected cells in both the TNF/ MEF and
WT MEF in the presence of neutralizing polyclonal anti-
IFN-a/h antibody. Again, a statistically significantly greater
number of cells were infected in the TNF/ MEF
population than in the WT MEF population, confirming
that TNF is itself protective against WNV infection. We
confirmed the importance of TNF by adding exogenous
recombinant TNF to WT, IFNAR/ and TNF/ MEF.
There was a slight but non-significant decrease in WNV
infection in the WT MEF but a statistically significant
increase in protection against infection when TNF was
added to the IFNAR/ or TNF/ MEF.
Together, these data indicate that endogenous IFN-a/h
and TNF secretion are both important in protection against
infection and that TNF can protect against infection in the
absence of IFN-a/h. The mechanism by which TNF can
protect against viral infection is not completely understood,
but TNF can enhance interferon synthesis and can also
block viral replication by interfering with the virus life
cycle, including viral entry (Herbein and O’Brien, 2000).
Addition of TNF did not completely reconstitute the
resistance of TNF/ MEF to the level of WT MEF. The
protective effect against WNV infection in MEF was
observed when TNF was added 1 h after viral inoculation
in these experiments. It is possible that a stronger antiviral
effect may have been seen if TNF treatment preceded or
accompanied virus inoculation. Clearly, the WT MEF may
not be free of endogenously produced TNF at these points,
although we cannot detect it in our experimental system.
Similar to endogenous IFN type 1 effects (Douglas et al.,
1994), therefore, naturally occurring low levels of TNF may
also inhibit WNV infection. In these circumstances, the
addition of TNF 1 h after WNV infection would not be
expected to fully reconstitute the same anti-viral effect as
clearly exists in the WT MEF. However, the possibility that
TNF would inhibit viral entry cannot be excluded in such
experiments and would conceal the intracellular antiviral
(i.e., post viral entry) effect demonstrated here.
As previously demonstrated in WNV-infected endothe-
lial cells (Shen et al., 1997), treatment with exogenous
TNF is associated with a small but significant increase in
the cell surface expression of MHC-I. The increase in cellsurface MHC-I expression induced by WNV and IFN-h
occurs on both WT and TNF/ MEF, indicating that TNF
is not required for MHC-I upregulation by WNV or IFN-h
(Fig. 2). Furthermore, both WNV and TNF, alone and in
combination, upregulate MHC-I expression on WT and
IFNAR/ MEF. However, the effects of TNF on WNV-
infected IFNAR/ MEF were considerably less than on
equivalent WT MEF, indicating that endogenously pro-
duced IFN-a/h has a significant effect on the upregulation
of cell surface MHC-1 by WNV, but endogenously
produced TNF does not (Fig. 3).
WNV has been demonstrated to upregulate MHC-I by
increasing transcription of MHC-I genes via activation of
the transcription factor NF-nB (Kesson and King, 2001),
while upregulation of MHC-I by IFNs is independent of NF-
nB (Cheng et al., 2004). We have shown that WNVactivates
NF-nB and upregulates MHC-I expression on TNF/
MEF, clearly demonstrating that the NF-nB activation and
MHC-I upregulation by WNVare independent of the actions
of endogenously produced TNF. The activation of NF-nB
by TNF has different kinetics from that of WNV. At a WNV
moi of 5, TNF-induced activation of NF-nB occurred earlier
than WNV-induced activation of TNF, although the kinetics
may change with differing moi. In addition, the activation of
NF-nB by TNF involves the p65, p50, and c-Rel proteins,
while activation of NF-nB by WNV involves only p65 and
p50. In summary, WNV infection of MEF is associated with
the production of endogenous TNF, which is associated with
protection from infection. WNV can upregulate MHC-I cell
surface expression by activating NF-nB in a TNF-inde-
pendent manner. Both TNF and WNV activate NF-nB, but
activate different NF-nB components and may have differ-
ing kinetics.
The upregulation of MHC-I by WNV, independently of
type 1 IFN and TNF, which in turn results in increased
WNV-specific cytotoxic T cell lysis of infected cells
(Kesson and King, 2001), raises the question as to how
this may impinge upon the interaction of this virus with the
vertebrate host immune system to advantage viral replica-
tion and transmission.Materials and methods
Isolation and culture of mouse embryonic fibroblasts
Specific pathogen free female mice of the strains C57Bl/6
(H-2b) wild type (WT), tumor necrosis factor gene deficient
(TNF/) (Korner et al., 1997), and 129  C57Bl/6 (H-2b)
interferon type 1 receptor gene knockout (IFNAR/) mice
(van den Broek et al., 1995) were used between the ages of 6
and 10 weeks. The guidelines from the National Health and
Medical Research Council of Australia were strictly adhered
to in all procedures relating to animals. The MEF were
isolated by trypsinization from foetuses of 14-day post-coital
WT, TNF/ and IFNAR/ mice. The primary MEF were
Y. Cheng et al. / Virology 329 (2004) 361–370368seeded at 1  106 per 175 cm 2 flask (Falcon, USA) and
maintained in Dulbecco’s Modified Eagles Medium
(DMEM) (Gibco, USA) supplemented with 10% foetal
bovine serum (FBS) (Commonwealth Serum Laboratories,
Australia) and antibiotics (200 units/ml penicillin G and 200
Ag/ml streptomycin) (DMEM/FBS) under standard culture
conditions (SCC) in a humidified atmosphere of 5% CO2 in
air at 37 8C until confluence. Primary MEF were trypsinized
and stored at 106 cells/ml in liquid nitrogen and used as stock
for later experiments, or passaged into fresh flasks. MEF
were used between passage 5 and 10 for experiments in vitro.
Preparation of virus stock
Vero cells were grown to confluence in DMEM/FBS
under SCC in 175 cm2 tissue culture flasks. At confluence,
the medium was removed and the cells infected with 108 pfu
WNV (Sarafend) in 1 ml of DMEM (i.e., at moi of 5) or
mock-infected with 1 ml DMEM alone for 1 h at 37 8C. At
this time, DMEM/FBS was added and the cells incubated
for 48 h under SCC. The supernatant was removed and
centrifuged to remove cellular debris, and the clarified
supernatant stored in aliquots and kept at 80 8C for use as
stock virus. Titres of virus stocks were determined by
enumeration of dead cell plaques after serial dilution of
virus on Vero cell monolayers and 3 days incubation.
Viral infection
MEF were trypsinized and seeded at 0.5  106 per well
in 6-well plates (Falcon, USA) with DMEM/FBS and
maintained overnight in SCC. The medium was removed
and replaced with 0.5 ml of WNV diluted in DMEM at 5 pfu
per cell or mock-infected with a similar dilution of super-
natant from uninfected vero cells diluted in DMEM, unless
otherwise stated, and incubated under SCC. After 1 h of
incubation, excess virus was removed and the culture dishes
were washed twice with 1 ml phosphate buffered saline
(PBS), and fresh DMEM/FBS was added for further
incubation.
Immunohistochemistry for labeling viral antigens
MEF were seeded in 24-well plates with sterile cover-
slips, and incubated overnight under SCC. They were then
infected with varying pfu of WNV per cell for 60 min under
SCC, washed, and incubated for 24 h. The coverslips with
infected MEF were washed with PBS twice, fixed with cold
acetone at 20 8C for 10 min. After two washes with PBS,
the cells were labeled with primary mouse anti-WNV
antibody for 60 min, washed with DMEM/FBS and FITC-
conjugated sheep anti-mouse IgG antibody (SAM-FITC)
(Silenus, Australia) was added for 60 min. The second
antibody was washed off with PBS, and Hoechst 33342
(bisbenzimide, 50 Ag/ml) (Sigma, USA) was added to aid
visualization of the MEF nuclei. The coverslips wereinverted and mounted on microscope slides with glycerol.
The percentage of infected cells was determined with a
fluorescence microscope by dividing the number of infected
MEF (green) by the number of nuclei of total cells (blue) in
a field of at least 100 cells and multiplying by 100. At least
five such fields were counted for each treatment, and the
mean and standard deviation calculated.
Semi-quantitative Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
RNA-extraction
WNV-infected or mock-infected MEF in 6-well-plates
were drained of media and 1 ml of TRIZOL Reagent
(Invitrogen, USA) was added to each well for 5 min. The
supernatants were collected and transferred to a clean 1.5 ml
Eppendorf tube where 200 Al of chloroform was added. The
solution was vortexed for 30 s, allowed to stand at room
temperature for 10 min, and centrifuged at 12,000  g for
10 min at 4 8C. The upper aqueous phase was immediately
and carefully transferred to a clean 1.5 ml Eppendorf tube
avoiding disturbance of the middle interphase layer. One ml
of isopropanol was added to the aqueous suspension and
mixed by vortex, incubated at room temperature for 10 min,
then centrifuged at 12,000  g for 10 min at 4 8C. The
supernatant was discarded, leaving the pellet which was
washed with 75% ethanol, and then centrifuged at 7500  g
for 10 min at 4 8C. The supernatant was carefully decanted
leaving the pellet at the bottom. The tube was inverted on a
paper towel to drain and air dry for 30 min. The RNA pellet
was resuspended in 100 Al of diethyl pyrocarbonate
(DEPC)-treated H2O (DEPCd H2O) (Sigma). The concen-
tration and purity of RNA was determined by spectropho-
tometry and specimens with an OD260/280 greater than 1.8
used as a source of RNA.
Reverse transcription
Isolated RNA (1 Ag) from each sample in 15 Al of
DEPCd H2O was denatured by incubation at 70 8C for 5 min,
4 8C for 3 min, and 25 8C for 5 min. The denatured RNAwas
mixed with the reverse transcription mixture containing 5 Al
of 5  RT buffer (Promega, USA), 1Al of random hexamer
oligo primers (Promega), 0.5 Al of RNAsin (Promega) and
1 Al of MLV reverse transcriptase (Promega), then
incubated at 37 8C for 60 min, 90 8C for 5 min, 4 8C for
5 min. The resultant cDNA was used for PCR or stored at
20 8C.
PCR and electrophoresis
The PCR mixture was made with cDNA (10 ng), MgCl2
(3 mM), 2.5 Al of 10 PCR buffer (Promega), 2 Al of dNTPs
(2.5 mM each nucleotide, Promega), 0.5 Al of each primer of
forward and reverse primers (5 AM), 0.2 Al of Taq polymer-
ase (5 units/Al, Promega). The primers for murine h-actin
used as house-keeping gene were 5V-TGG GTC AGA AGG
ACT CCT ATG-3V and 5V-CAG GCA GCT CAT AGC TCT
Y. Cheng et al. / Virology 329 (2004) 361–370 369TCT-3V. The TNF-specific primers were 5V-GAT CTC AAA
GAC AAC CAA CTAGTG-3V and 5V-CTC CAG CTG GAA
GAC TCC TCC CAG-3V. The PCR reaction was started with
denaturation at 95 8C for 3 min, then performed for 40 cycles
of the following: denaturation at 95 8C for 30 s, annealing at
54 8C for 30 s, elongation at 72 8C for 40 s. The reaction was
finished with further elongation at 72 8C for 7 min, then held
at 4 8C. PCR-amplified double-stranded DNAwas separated
on a 2% agarose gel with electrophoresis apparatus, stained
with ethidium bromide, washed with tap water, and then
photographed.
ELISA
A mouse TNF-a Immunoassay (R&D Systems, USA)
was employed for detection of soluble TNF in MEF culture
supernatant. Briefly, 50 Al of assay diluent and 50 Al of
Standard, Control, or supernatant sample per reaction were
added to each well and mixed by tapping the plate for a
minute, incubated for 2 h at room temperature, then washed
five times with wash buffer. After washing, 100 Al of
Conjugate Solution per well was added, incubated for 2 h at
room temperature, washed five times with washing buffer,
followed by 100 Al Substrate Solution per well, and
incubation for 30 min at room temperature. Finally, 100 Al
Stop Solution was added to each well and mixed. Optical
density (OD) of the reactions was read at 450 nm (reference
wavelength at 540 nm or 570 nm), and each sample was run
in duplicate and the mean calculated. The standard curve
was constructed from the OD of the standard control run in
serial dilution. The concentration of soluble TNF was
determined from the standard curve.
Electromobility shift assays (EMSA)
Total cell protein extracts were obtained from MEF using
a high salt detergent buffer A (20 mM HEPES, pH 7.9, 350
mMNaCl, 20% (w/v) glycerol, 1% NP-40, 1 mMMgCl2, 0.5
mMEDTA, 0.1 mMEGTA, 0.5 mMDTT, 0.1% PMSF, 1.0%
apoprotinin). Cells were harvested by trypsinization and
centrifugation, washed once in ice-cold PBS and resus-
pended in four volumes of extraction buffer (buffer A). The
cell lysate was incubated on ice for 30 min, then centrifuged
for 5 min at 13,000  g at 4 8C. The protein content in the
supernatant was determined by the Bradford dye-binding
method (Bio Rad, USA) and stored at 80 8C until use.
Equal amounts of cell protein (10 Ag) were incubated for
30 min at 4 8C in Buffer B (10 mM HEPES, pH 7.9; 12 mM
KCl, 1.5 mM MgCl2, 0.5 mM EDTA, 2 mM DTT and 0.1%
PMSF) with 20 Ag BSA and 2 Ag poly (dI/dC) with 1 ng of
probe. The 32P end-labeled double-stranded oligonucleotide
probe containing the consensus sequence for NF-nB
(Promega) was end-labeled with (g-32P)-ATP by using T4
polynucleotide kinase (Promega). DNA-NF-nB complexes
were resolved from the free-labeled DNA by electrophoresis
in 5% polyacrylamide gels containing 50 mM Tris–HCl,(pH 8.5), 200 mM glycine, and 1 mM EDTA. The gels were
dried and autoradiographed. For the supershift assays,
analysis was carried out with specific antibodies to the
p50, p65 (RelA) and c-Rel subunits of NF-nB (Santa Cruz,
USA) by adding them to the binding reaction for 2 h at 4 8C
before adding the labeled oligonucleotide.
Cell labeling and flow cytometry
After treatment, MEF were washed twice with PBS,
coverslips were removed for confirmation of WNV infection
(see Immunohistochemistry for labeling viral antigens) and
the cells remaining in the wells were dispersed by
trypsinization (1 ml of 0.05% w/v trypsin, 1 mM EDTA
in calcium and magnesium-free PBS for 2 min at 37 8C) and
then washed in DMEM/FBS before the addition of the
primary antibody, anti-H-2KbDb (Immunogen, USA). Cells,
5  105, were pelleted by centrifugation at 400 g for 3 min
and resuspended in 50 Al of DMEM/FBS containing
primary antibody for 45 min at 4 8C. After the incubation,
MEF were washed twice with PBS, and resuspended in 5 Al
of SAM-FITC for 45 min at 4 8C. At this time, the cells
were again washed twice with PBS and resuspended in 250
Al of DMEM. Fluorescence was measured by flow
cytometry on a FACScalibur (Becton-Dickinson, USA)
with an air-cooled ion laser set at 488 nm for excitation.
Fluorescence was measured between 515 and 545 nm for
FITC-labeled cells. Forward and side scatter measurements
were within the same range for all populations. Data were
collected from 104 cells for each sample and presented as
histograms.
Statistical analysis
Student’s t test using Excel (Microsoft, USA) was used
to determine the statistical significance of the difference
between two experimental tests. P values less than 0.05
were deemed significant.Acknowledgments
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